Growth kinetics and immune response of chimeric foot-and-mouth disease virus serotype 'O' produced through replication competent mini genome of serotype Asia 1, 63/72, in BHK cell lines.

[1]  F. Maree,et al.  Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs. , 2011, The Journal of general virology.

[2]  E. Domingo,et al.  Viral Genome Segmentation Can Result from a Trade-Off between Genetic Content and Particle Stability , 2011, PLoS genetics.

[3]  G. R. Reddy,et al.  Construction of genome-length cDNA for foot-and-mouth disease virus serotype Asia 1 IND 63/72 vaccine strain , 2011 .

[4]  N. Govindasamy,et al.  Study of a chimeric foot-and-mouth disease virus DNA vaccine containing structural genes of serotype O in a genome backbone of serotype Asia 1 in guinea pigs. , 2010, Acta virologica.

[5]  S. Parida.  Vaccination against foot-and-mouth disease virus: strategies and effectiveness , 2009, Expert review of vaccines.

[6]  Junzheng Du,et al.  Complete nucleotide sequence of a Chinese serotype Asia1 vaccine strain of foot-and-mouth disease virus , 2007, Virus Genes.

[7]  S. Reid,et al.  Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. , 2006, Vaccine.

[8]  T. Doel,et al.  Thermal stability of foot-and-mouth disease virus , 2005, Archives of Virology.

[9]  H. Bao,et al.  Generation of an infectious cDNA clone of an FMDV strain isolated from swine. , 2004, Virus research.

[10]  P. Mason,et al.  Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. , 2004, The Journal of general virology.

[11]  P. Mason,et al.  Construction and Evaluation of a Recombinant Foot‐and‐Mouth Disease Virus , 2002 .

[12]  V. Racaniello.  Picornaviridae : the viruses and their replication , 2001 .

[13]  P. Mason,et al.  Genetic Determinants of Altered Virulence of Taiwanese Foot-and-Mouth Disease Virus , 2000, Journal of Virology.

[14]  E. Domingo,et al.  Multiple Virulence Determinants of Foot-and-Mouth Disease Virus in Cell Culture , 1998, Journal of Virology.

[15]  P. Mason,et al.  Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle , 1997, Journal of virology.

[16]  P. Mason,et al.  Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity , 1997, Journal of virology.

[17]  I. Tubulekas,et al.  Alphaviruses as vectors for gene delivery. , 1996, Trends in biotechnology.

[18]  M. G. Mateu,et al.  Antibody recognition of picornaviruses and escape from neutralization: a structural view. , 1995, Virus research.

[19]  R. Hodges,et al.  Relationship of sidechain hydrophobicity and α‐helical propensity on the stability of the single‐stranded amphipathic α‐helix , 1995 .

[20]  F. Brown.  Antibody recognition and neutralization of foot-and-mouth disease virus , 1995 .

[21]  P. Mason,et al.  Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV , 1994, Journal of virology.

[22]  D. Stuart,et al.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites , 1994, Journal of virology.

[23]  R. Venkataramanan,et al.  Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72. , 1992, Biochemistry International.

[24]  E. Domingo,et al.  Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture , 1990, Journal of virology.

[25]  H. Bahnemann.  Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine , 1990, Vaccine.

[26]  G. Maass,et al.  Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA , 1990, Journal of virology.

[27]  J. Dunn,et al.  Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts , 1987, Journal of virology.

[28]  B. Moss,et al.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Baltimore,et al.  Cloned poliovirus complementary DNA is infectious in mammalian cells. , 1981, Science.

[30]  J. Booth,et al.  Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains , 1978, Journal of Hygiene.

[31]  J. Crowther,et al.  Enzyme-labelled immunosorbent assay techniques in foot-and-mouth disease virus research , 1978, Journal of Hygiene.

[32]  J. Graves.  Immune response of cattle to different serotype antigens in monovalent and trivalent foot-and-mouth disease vaccines. , 1969, Journal of Immunology.